Bioventus Inc. · NASDAQ:BVS
Bioventus — Investor Presentation (March 2026)
12 slides from Bioventus's investor presentation, March 2026
Slide 1: Helping Patients Recover and Live Life to the Fullest
Helping Patients Recover and Live Life to the Fullest Rob Claypoole, President and CEO Mark Singelton, Senior Vice-President and CFO Dave Crawford, Vice-President Treasurer and Investor Relations Corporate Presentation March 2026
Slide 2: Forward Looking Statements
Forward Looking Statements This presentation contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements contained in this presentation that do not relate to matter
Slide 3: Bioventus: A Compelling Investment Opportunity
Bioventus: A Compelling Investment Opportunity Market Leadership High-Growth Prospects Value Creation A category or a growth leader Advancing category leadership Multiple, durable paths to future across entire portfolio with emerging high-growth value creation opportunities Restorative Therapies Acc
Slide 4: Next Phase: Focused on Accelerating Growth and Profitability
Next Phase: Focused on Accelerating Growth and Profitability 2022: Portfolio with Unrealized Potential 2025: Growth Portfolio Advanced Future: Ignite Growth Potential 1% Organic Revenue Growth 7.5% Organic Revenue Growth* 10%+ Organic Revenue Growth 13% Adj. EBITDA Margin 20.5% Adj. EBITDA Margin* ~
Slide 5: Across a Diverse Portfolio Bioventus is Either a Category or Growth Leader
Across a Diverse Portfolio Bioventus is Either a Category or Growth Leader Hyaluronic Platelet-Rich Peripheral Nerve Acid (HA) Plasma (PRP) Stimulation (PNS) 1 Pain Treatments Ultrasonics Bone Graft Substitutes (BGS) 2 Surgical Solutions Fracture Care 3 Restorative Therapies 2025 J.P. Morgan Healthc
Slide 6: Bioventus Growth Portfolio: Our Core Funds Our Future
Bioventus Growth Portfolio: Our Core Funds Our Future Early stage and exciting long-term Emerging PNS and growth engines PNS & PRP PRP Delivering strong growth with additional near-term Expansion acceleration and expected to become more material Ultrasonics Ultrasonics & International and Internatio
Slide 7: 2026: Investing In and Igniting Powerful Growth Drivers
2026: Investing In and Igniting Powerful Growth Drivers Focus: Patients suffering from chronic peripheral pain Focus: Patients suffering from Spine degeneration or deformation Market: $250M today, 24%+ CAGR Market: >$1B today, 7%+ CAGR Why We Win: Peripheral Nerve • Only product designed for periphe
Slide 8: Portfolio Evolution Raises WAMGR and Accelerates Growth Profile
Portfolio Evolution Raises WAMGR and Accelerates Growth Profile BVS Portfolio Today Future BVS Portfolio Investment Priorities Emerging Milestone-based expansion Emerging of PNS sales force Targeted increase in Expansion International sales resources Strategic marketing to raise Core Expansion Core
Slide 9: Strong P&L Enables Investment With Profit Acceleration
Strong P&L Enables Investment With Profit Acceleration Peer Leading Gross Margin + Substantial Growth Investment Continued Earnings Above Market Expansion Revenue Growth 2026 EPS Growth Above Revenue Growth 9 March 2026 Corporate Presentation
Slide 10: Accelerating Cash Flow, Enhancing Liquidity, and Reducing Net Leverage
Accelerating Cash Flow, Enhancing Liquidity, and Reducing Net Leverage Creates Capital Allocation Optionality 2025 Accomplishments Capital Allocation Discipline Further debt reduction – clear path to leverage 2025 cash flow almost 2x 2024* 1 below 2x 2 M&A – only if highly synergistic and exceeds De
Slide 11: Bioventus: A Compelling Investment Opportunity With Multiple Value Creation Drivers
Bioventus: A Compelling Investment Opportunity With Multiple Value Creation Drivers 1 Ignite Expansion & Emerging Platforms to Further Accelerate Growth 2 Deliver Increased Profitability & Strengthened Earnings Power 3 Generate Significant Free Cash Flow With Capital Deployment Optionality 11 March
Slide 12: Helping Patients Recover and Live Life to the Fullest
Helping Patients Recover and Live Life to the Fullest